Initiative in LYon for Lung cAncer Screening Development - Prevalence Study
ILYAD1
1 other identifier
observational
4,595
1 country
1
Brief Summary
Screening at-risk subjects with low-dose computed tomography (CT) efficiently reduces lung cancer specific mortality. However screening efficiency relies on the at-risk population's criteria definition and its participation rate to the screening. In France, there are concerns regarding the participation rates to national cancer screening that are quite low (around 50% and 32% of the eligible population for breast cancer and colorectal cancer respectively). Before organizing national lung cancer screening it is then crucial to determine the factors impacting the at-risk subjects willingness to participate in lung cancer screening. The Lyon University Hospital is the second biggest hospital in France with more than 23,000 employees distributed among more than 160 professions representing every level of education or working conditions. Its population is heterogeneous and wide enough to perform a prevalence study assessing the willingness to participate among the at-risk population. ILYAD is a prospective study performed by anonymous questionnaires that will be submitted to the 23,000 employees of the Lyon University Hospital. The study main objective is to evaluate the at-risk population presence in the Lyon University Hospital population, as defined by NELSON criteria and selection criteria for lung cancer screening (PLCOm2012 scoring), and its willingness to participate to a lung-cancer screening with low-dose CT. This might help further efficient national lung cancer screening campaign organization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2020
CompletedFirst Posted
Study publicly available on registry
January 27, 2020
CompletedStudy Start
First participant enrolled
October 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 14, 2021
CompletedJuly 13, 2021
July 1, 2021
3 months
January 22, 2020
July 12, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Number of employees belonging to the at-risk population for lung cancer and consequently eligible to lung cancer screening.
High-risk ever-smokers are defined as ever-smokers aged 55-74 years old, having smoked \>15 cigarettes per day for \>25 years or \>10 cigarettes for \>30 years and with ≤15 years since cessation for quitters.
Day 0 (at inclusion)
Study Arms (1)
Lyon University Hospital employees
Interventions
The objective is to evaluate the eligibility of the responders, as defined by NELSON criteria and PLCOm2012 scoring, and their willingness to participate to a lung-cancer screening with low-dose computed tomography.
Eligibility Criteria
The Civil Hospices of Lyon is the second largest university hospital in France, with 23000 staff.
You may qualify if:
- Aged ≥ 18 years old
- Employee from the Lyon University Hospital (receiving salary from the Lyon University Hospital)
- Person who has willingness to respond the survey
You may not qualify if:
- Employees not hired by the Lyon University Hospital
- Employees who have not willingness to participate in the survey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospices Civils de Lyon
Lyon, 69000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2020
First Posted
January 27, 2020
Study Start
October 31, 2020
Primary Completion
January 14, 2021
Study Completion
January 14, 2021
Last Updated
July 13, 2021
Record last verified: 2021-07